Search results for “site:nih.gov”

Page 8 of about 453 results

ncbi.nlm.nih.gov pubmed › 32368532

Stability and infectivity of coronaviruses in inanimate environments

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious virus that can transmit through respiratory droplets, aerosols, or contacts. Frequent touching of contaminated surfaces in public areas is therefore a...

ncbi.nlm.nih.gov pubmed › 32373461

An environmental and health perspective for COVID-19 outbreak: Meteorology and air quality influence, sewage epidemiology indicator, hospitals disinfection, drug therapies and recommendations

This Opinion Paper wishes to provide a summary of recent findings and solutions for a better understanding of the environmental and health problems associated with COVID-19. The list of topics covered is large: meteorology and air quality...

ncbi.nlm.nih.gov pubmed › 32389849

From SARS to COVID-19: What we have learned about children infected with COVID-19

Based on these early observations, as pediatricians, this review put forward some thoughts on children's COVID-19 and gave some recommendations to contain the disease.

ncbi.nlm.nih.gov pubmed › 32412088

Neurological Manifestations of COVID-19: A systematic review and current update

The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in December of 2019 in the city of Wuhan, China. Since the outbreak, various reports detail its symptoms and outcomes, primarily...

ncbi.nlm.nih.gov pubmed › 32416357

Effects of air pollutants on the transmission and severity of respiratory viral infections

Particulate matter, sulfur dioxide, nitrogen oxides, ozone, carbon monoxide, volatile organic compounds (VOCs) and polycyclic aromatic hydrocarbons (PAHs) are among the outdoor air pollutants that are major factors in diseases, causing...

ncbi.nlm.nih.gov pubmed › 32425996

A systematic review of asymptomatic infections with COVID-19

Since the outbreak of coronavirus disease 2019 (COVID-19) in late December 2019, it has brought significant harm and challenges to over 200 countries and regions around the world. However, there is increasing evidence that many patients...

ncbi.nlm.nih.gov pubmed › 32442793

Changes in population movement make COVID-19 spread differently from SARS

This comment discusses the contribution of population movement to the spread of COVID-19, with a reference to the spread of SARS 17 years ago. We argue that the changing geography of migration, the diversification of jobs taken by...

ncbi.nlm.nih.gov pubmed › 32446821

Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The "Gabrin sign"

Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The "Gabrin sign"

ncbi.nlm.nih.gov pubmed › 32447629

COVID-19 and NSAIDS: A Narrative Review of Knowns and Unknowns

Concern about the appropriate role of nonsteroidal anti-inflammatory drugs (NSAIDs) in COVID-19 speculate that NSAIDs, in particular ibuprofen, may upregulate the entry point for the virus, the angiotensin-converting enzyme (ACE) 2...